SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 72 filers reported holding SURFACE ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,891 | +24.4% | 6,774 | 0.0% | 0.00% | – |
| Q1 2023 | $4,734 | -75.2% | 6,774 | -70.9% | 0.00% | – |
| Q4 2022 | $19,061 | -49.8% | 23,245 | -36.5% | 0.00% | – |
| Q3 2022 | $38,000 | -41.5% | 36,619 | -7.8% | 0.00% | – |
| Q2 2022 | $65,000 | -14.5% | 39,736 | +288.9% | 0.00% | – |
| Q2 2021 | $76,000 | -39.2% | 10,217 | -24.8% | 0.00% | – |
| Q4 2020 | $125,000 | – | 13,578 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 2,945,453 | $22,297,000 | 7.41% |
| ACT CAPITAL MANAGEMENT, LLC | 170,500 | $1,291,000 | 0.67% |
| SummerHaven Investment Management, LLC | 128,078 | $970,000 | 0.57% |
| Parkman Healthcare Partners LLC | 248,267 | $1,879,000 | 0.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $379,000 | 0.21% |
| C M BIDWELL & ASSOCIATES LTD | 33,030 | $250,000 | 0.17% |
| ARK Investment Management | 4,618,354 | $34,961,000 | 0.08% |
| Knights of Columbus Asset Advisors LLC | 114,594 | $867,000 | 0.08% |
| Orbimed Advisors | 909,666 | $6,886,000 | 0.08% |
| HighVista Strategies LLC | 13,932 | $105,000 | 0.07% |